Literature DB >> 21501849

The stress hormone system in various sleep disorders.

Zuzana Lattova1, Marietta Keckeis, Eszter Maurovich-Horvat, Thomas C Wetter, Johanna Wilde-Frenz, Andreas Schuld, Thomas Pollmächer.   

Abstract

Hypothalamic-pituitary-adrenal (HPA)-system activity is regulated by the suprachiasmatic nucleus, the primary endogenous circadian pacemaker. In addition, sleep plays an important modulatory role. However, data on HPA-system activity in sleep disorders are quite conflicting. A sensitive challenge test to assess negative feedback sensitivity of the HPA-system like the dexamethasone/corticotropin-releasing-hormone (DEX/CRH)-test has never been used so far in sleep disorders. Therefore we studied 25 obstructive sleep apnea (OSA) patients, 18 restless legs syndrome (RLS) patients, 21 patients with primary insomnia and compared them to 33 healthy controls. The dynamic response of the HPA-system was assessed by the DEX/CRH-test which combines suppression (dexamethasone) and stimulation (CRH) of the stress hormone system. After HPA-axis suppression the number of non-suppressors did not differ among groups indicating normal negative feedback sensitivity. In RLS patients ACTH levels were slightly lower compared to controls while cortisol levels were similar between groups. Following CRH stimulation we did not detect differences in ACTH- or cortisol levels and adrenocortical responsitivity to ACTH was comparable between groups. These results for the first time document normal HPA-system feedback sensitivity in various sleep disorders and suggest that abnormalities of the stress hormone system in affective disorders are unlikely due to concomitant sleep problems.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21501849     DOI: 10.1016/j.jpsychires.2011.03.013

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  16 in total

1.  Altered Resting Cerebral Blood Flow in Obstructive Sleep Apnea: A Helpful Change or Not?

Authors:  Paul M Macey
Journal:  Sleep       Date:  2015-09-01       Impact factor: 5.849

2.  Familial Risk for Insomnia Is Associated With Abnormal Cortisol Response to Stress.

Authors:  Christopher L Drake; Philip Cheng; David M Almeida; Thomas Roth
Journal:  Sleep       Date:  2017-10-01       Impact factor: 5.849

3.  Habitual sleep duration associated with self-reported and objectively determined cardiometabolic risk factors.

Authors:  Michael A Grandner; Subhajit Chakravorty; Michael L Perlis; Linden Oliver; Indira Gurubhagavatula
Journal:  Sleep Med       Date:  2013-10-28       Impact factor: 3.492

Review 4.  OSA and Cardiovascular Risk in Pediatrics.

Authors:  David F Smith; Raouf S Amin
Journal:  Chest       Date:  2019-02-18       Impact factor: 9.410

5.  Hyperarousal in insomnia: pre-sleep and diurnal cortisol levels in response to chronic zolpidem treatment.

Authors:  Timothy Roehrs; Thomas Roth
Journal:  Sleep Med       Date:  2019-04-25       Impact factor: 3.492

Review 6.  Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome.

Authors:  Farhan H Khan; Caitlyn D Ahlberg; Christopher A Chow; Divya R Shah; Brian B Koo
Journal:  J Neurol       Date:  2017-02-24       Impact factor: 4.849

Review 7.  Sleep: important considerations for the prevention of cardiovascular disease.

Authors:  Michael A Grandner; Pamela Alfonso-Miller; Julio Fernandez-Mendoza; Safal Shetty; Sundeep Shenoy; Daniel Combs
Journal:  Curr Opin Cardiol       Date:  2016-09       Impact factor: 2.161

Review 8.  Addressing sleep disturbances: an opportunity to prevent cardiometabolic disease?

Authors:  Michael A Grandner
Journal:  Int Rev Psychiatry       Date:  2014-04

9.  Morning cortisol levels and glucose metabolism parameters in moderate and severe obstructive sleep apnea patients.

Authors:  Josko Bozic; Tea Galic; Daniela Supe-Domic; Natalija Ivkovic; Tina Ticinovic Kurir; Zoran Valic; Josip Lesko; Zoran Dogas
Journal:  Endocrine       Date:  2016-03-21       Impact factor: 3.633

10.  Alterations in hypothalamus-pituitary-adrenal/thyroid axes and gonadotropin-releasing hormone in the patients with primary insomnia: a clinical research.

Authors:  Lan Xia; Gui-Hai Chen; Zhi-Hua Li; Song Jiang; Jianhua Shen
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.